BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Diabetes

The World Journal of Diabetes (WJD) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of diabetes.  It was launched on March 15, 2010 and is published monthly (12 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage diabetologists worldwide to submit manuscripts to the WJD describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJD are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJD’s acceptance rate: 57%. Submit here >>

2016 Published Issues
18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1

Lu Qi, MD, PhD, Associate Professor; Jingbo Zhao, PhD, Associate Professor


Emerging Sources Citation Index (Web of Science), PubMed, and PubMed Central.

Journal Metrics

There is currently no impact factor.


1948-9358 (online)

Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk  
Antonino Di Pino, Francesca Urbano, Salvatore Piro, Francesco Purrello, Agata Maria Rabuazzo
World J Diabetes 7(18):423-432. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.423
Nitrate-nitrite-nitrosamines exposure and the risk of type 1 diabetes: A review of current data  
Zahra Bahadoran, Asghar Ghasemi, Parvin Mirmiran, Fereidoun Azizi, Farzad Hadaegh
World J Diabetes 7(18):433-440. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.433
Glucagon-like peptide-1 receptor agonists favorably address all components of metabolic syndrome  
Sanjay Chatterjee, Samit Ghosal, Saurav Chatterjee
World J Diabetes 7(18):441-448. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.441
Observational Study
Impact of diabetes mellitus on risk of cardiovascular disease and all-cause mortality: Evidence on health outcomes and antidiabetic treatment in United States adults  
Longjian Liu, Barbara Simon, Jinggaofu Shi, Arshpreet Kaur Mallhi, Howard J Eisen
World J Diabetes 7(18):449-461. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.449
Cost of illness among patients with diabetic foot ulcer in Turkey  
Ergun Oksuz, Simten Malhan, Bilge Sonmez, Rukiye Numanoglu Tekin
World J Diabetes 7(18):462-469. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.462
Predictors of hypoglycemia in insulin-treated patients with type 2 diabetes mellitus in Basrah  
Dhuha Tarik Nassar, Omran S Habib, Abbas Ali Mansour
World J Diabetes 7(18):470-480. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.470
Letters To The Editor
Response to comment on: Statin use and risk of diabetes mellitus  
Bharti Chogtu, Rahul Magazine, Kurady Laxminarayana Bairy
World J Diabetes 7(18):481-482. Published online Oct 15, 2016. doi: 10.4239/wjd.v7.i18.481